(19)
(11) EP 0 779 813 A1

(12)

(43) Date of publication:
25.06.1997 Bulletin 1997/26

(21) Application number: 95933745.0

(22) Date of filing: 06.09.1995
(51) International Patent Classification (IPC): 
A61K 38/ 22( . )
A61K 31/ 66( . )
A61K 38/ 23( . )
A61K 45/ 00( . )
A61P 5/ 12( . )
A61P 43/ 00( . )
A61K 31/ 565( . )
A61K 31/ 675( . )
A61K 38/ 29( . )
A61P 3/ 02( . )
A61P 19/ 10( . )
(86) International application number:
PCT/US1995/011336
(87) International publication number:
WO 1996/007418 (14.03.1996 Gazette 1996/12)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

(30) Priority: 09.09.1994 US 19940303981

(71) Applicant: THE PROCTER & GAMBLE COMPANY
Cincinnati, Ohio 45202 (US)

(72) Inventors:
  • GEDDES, Ann Dunbar
    Oxford, OH 45056 (US)
  • BEVAN, John Althorp
    Cincinnati, OH 45208 (US)

(74) Representative: Woof, Victoria, et al 
Procter & Gamble Pharmaceuticals Ltd., Patent Department, Lovett House, Lovett Road
Staines, Middlesex TW18 3AZ
Staines, Middlesex TW18 3AZ (GB)

   


(54) PHOSPHONATES AND PARATHYROID HORMONE FOR OSTEOPOROSIS